{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T05:03:46Z","timestamp":1772341426287,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T00:00:00Z","timestamp":1531094400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T00:00:00Z","timestamp":1531094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006955","name":"Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["MH104506"],"award-info":[{"award-number":["MH104506"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006955","name":"Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["MH111461"],"award-info":[{"award-number":["MH111461"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006955","name":"Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["GM108799"],"award-info":[{"award-number":["GM108799"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006955","name":"Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["GM108580"],"award-info":[{"award-number":["GM108580"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013395","name":"Taylor Family Institute for Innovative Psychiatric Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013395","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Taylor Family Institute for Innovative Psychiatric Research; Center for the Investigation of Membrane Excitability Diseases at Washington University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Many GABAergic drugs are in clinical use as anesthetics, sedatives, or anxiolytics. We have investigated the actions of the combinations of the neuroactive steroid 3\u03b1-hydroxy-5\u03b1-pregnane-11,20-dione (alfaxalone) with the intravenous anesthetic propofol or the benzodiazepine diazepam. The goal of the study was to determine whether coapplication of alfaxalone reduces the effective doses and concentrations of propofol and diazepam. Behavioral effects of alfaxalone, propofol, diazepam, and the combinations of the drugs were evaluated during a 30-min activity test in mice. Functional effects of the individual drugs and drug combinations were tested by measuring the decay times of spontaneous inhibitory postsynaptic currents in rat hippocampal neurons, and peak current responses from heterologously expressed concatemeric \u03b11\u03b22\u03b32L GABA<jats:sub>A<\/jats:sub>receptors. Co-administration of alfaxalone increased the sedative actions of propofol and diazepam in mice. The combination of alfaxalone with propofol or diazepam increased the decay times of sIPSCs and shifted the concentration-response relationships for GABA-activated receptors to lower transmitter concentrations. We infer that alfaxalone acts as a co-agonist to enhance the GABAergic effects of propofol and diazepam. We propose that co-administration of alfaxalone, and possibly other neuroactive steroids, can be employed to reduce dosage requirements for propofol and diazepam.<\/jats:p>","DOI":"10.1038\/s41598-018-28754-7","type":"journal-article","created":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T13:38:34Z","timestamp":1530625114000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Enhanced GABAergic actions resulting from the coapplication of the steroid 3\u03b1-hydroxy-5\u03b1-pregnane-11,20-dione (alfaxalone) with propofol or diazepam"],"prefix":"10.1038","volume":"8","author":[{"given":"Lily Q.","family":"Cao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael C.","family":"Montana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison L.","family":"Germann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2750-3877","authenticated-orcid":false,"given":"Sampurna","family":"Chakrabarti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Mennerick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla M.","family":"Yuede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David F.","family":"Wozniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex S.","family":"Evers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustav","family":"Akk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,9]]},"reference":[{"key":"28754_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.neuropharm.2008.07.045","volume":"56","author":"RW Olsen","year":"2009","unstructured":"Olsen, R. W. & Sieghart, W. GABAA receptors: subtypes provide diversity of function and pharmacology. Neuropharmacology 56, 141\u2013148 (2009).","journal-title":"Neuropharmacology"},{"issue":"Suppl 1","key":"28754_CR2","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1038\/sj.bjp.0706441","volume":"147","author":"NP Franks","year":"2006","unstructured":"Franks, N. P. Molecular targets underlying general anaesthesia. Br J Pharmacol 147(Suppl 1), S72\u201381 (2006).","journal-title":"Br J Pharmacol"},{"key":"28754_CR3","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1146\/annurev.ne.17.030194.003033","volume":"17","author":"RL Macdonald","year":"1994","unstructured":"Macdonald, R. L. & Olsen, R. W. GABAA receptor channels. Annu Rev Neurosci 17, 569\u2013602 (1994).","journal-title":"Annu Rev Neurosci"},{"key":"28754_CR4","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/0952-8180(89)90080-9","volume":"1","author":"MA Skues","year":"1989","unstructured":"Skues, M. A. & Prys-Roberts, C. The pharmacology of propofol. J Clin Anesth 1, 387\u2013400 (1989).","journal-title":"J Clin Anesth"},{"key":"28754_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/bja\/60.1.3","volume":"60","author":"MA Claeys","year":"1988","unstructured":"Claeys, M. A., Gepts, E. & Camu, F. Haemodynamic changes during anaesthesia induced and maintained with propofol. Br J Anaesth 60, 3\u20139 (1988).","journal-title":"Br J Anaesth"},{"key":"28754_CR6","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1476-5381.1972.tb07245.x","volume":"44","author":"JW Dundee","year":"1972","unstructured":"Dundee, J. W. & Pandit, S. K. Anterograde amnesic effects of pethidine, hyoscine and diazepam in adults. Br J Pharmacol 44, 140\u2013144 (1972).","journal-title":"Br J Pharmacol"},{"key":"28754_CR7","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/0278-2391(92)90061-4","volume":"50","author":"PM Loeffler","year":"1992","unstructured":"Loeffler, P. M. Oral benzodiazepines and conscious sedation: a review. J Oral Maxillofac Surg 50, 989\u2013997 (1992).","journal-title":"J Oral Maxillofac Surg"},{"key":"28754_CR8","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1213\/ANE.0000000000001429","volume":"123","author":"B Drexler","year":"2016","unstructured":"Drexler, B., Balk, M. & Antkowiak, B. Synergistic modulation of \u03b3-aminobutyric acid type A receptor-mediated synaptic inhibition in cortical networks by allopregnanolone and propofol. Anesth Analg 123, 877\u2013883 (2016).","journal-title":"Anesth Analg"},{"key":"28754_CR9","doi-asserted-by":"publisher","first-page":"5446","DOI":"10.1111\/bph.12861","volume":"171","author":"P Li","year":"2014","unstructured":"Li, P. et al. The neurosteroid 5\u03b2-pregnan-3\u03b1-ol-20-one enhances actions of etomidate as a positive allosteric modulator of \u03b11\u03b22\u03b32L GABA receptors. Br J Pharmacol 171, 5446\u20135457 (2014).","journal-title":"Br J Pharmacol"},{"key":"28754_CR10","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1152\/jn.00346.2009","volume":"102","author":"M Chisari","year":"2009","unstructured":"Chisari, M. et al. The influence of neuroactive steroid lipophilicity on GABAA receptor modulation: evidence for a low-affinity interaction. J Neurophysiol 102, 1254\u20131264 (2009).","journal-title":"J Neurophysiol"},{"key":"28754_CR11","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1124\/mol.115.102202","volume":"89","author":"S Chakrabarti","year":"2016","unstructured":"Chakrabarti, S. et al. Comparison of steroid modulation of spontaneous inhibitory postsynaptic currents in cultured hippocampal neurons and steady-state single-channel currents from heterologously expressed \u03b11\u03b22\u03b32L GABAA receptors. Mol Pharmacol 89, 399\u2013406 (2016).","journal-title":"Mol Pharmacol"},{"key":"28754_CR12","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1006\/jmcc.1998.0655","volume":"30","author":"BK Slinker","year":"1998","unstructured":"Slinker, B. K. The statistics of synergism. J Mol Cell Cardiol 30, 723\u2013731 (1998).","journal-title":"J Mol Cell Cardiol"},{"key":"28754_CR13","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/0304-3959(93)90006-B","volume":"55","author":"RM Caudle","year":"1993","unstructured":"Caudle, R. M. & Williams, G. M. The misuse of analysis of variance to detect synergy in combination drug studies. Pain 55, 313\u2013317 (1993).","journal-title":"Pain"},{"key":"28754_CR14","doi-asserted-by":"crossref","first-page":"32768","DOI":"10.1016\/S0021-9258(20)30057-0","volume":"269","author":"SJ Mihic","year":"1994","unstructured":"Mihic, S. J., Whiting, P. J., Klein, R. L., Wafford, K. A. & Harris, R. A. A single amino acid of the human \u03b3-aminobutyric acid type A receptor \u03b32 subunit determines benzodiazepine efficacy. J Biol Chem 269, 32768\u201332773 (1994).","journal-title":"J Biol Chem"},{"key":"28754_CR15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0022-3565(25)10610-1","volume":"274","author":"E Sanna","year":"1995","unstructured":"Sanna, E. et al. Actions of the general anesthetic propofol on recombinant human GABAA receptors: influence of receptor subunits. J Pharmacol Exp Ther 274, 353\u2013360 (1995).","journal-title":"J Pharmacol Exp Ther"},{"key":"28754_CR16","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/j.1476-5381.1993.tb12866.x","volume":"108","author":"AL Horne","year":"1993","unstructured":"Horne, A. L., Harkness, P. C., Hadingham, K. L., Whiting, P. & Kemp, J. A. The influence of the \u03b32L subunit on the modulation of responses to GABAA receptor activation. Br J Pharmacol 108, 711\u2013716 (1993).","journal-title":"Br J Pharmacol"},{"key":"28754_CR17","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0026-895X(25)00452-3","volume":"39","author":"G Puia","year":"1991","unstructured":"Puia, G., Vicini, S., Seeburg, P. H. & Costa, E. Influence of recombinant \u03b3-aminobutyric acid-A receptor subunit composition on the action of allosteric modulators of \u03b3-aminobutyric acid-gated Cl- currents. Mol Pharmacol 39, 691\u2013696 (1991).","journal-title":"Mol Pharmacol"},{"key":"28754_CR18","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/ACO.0b013e328354feea","volume":"25","author":"SA Forman","year":"2012","unstructured":"Forman, S. A. Monod-Wyman-Changeux allosteric mechanisms of action and the pharmacology of etomidate. Curr Opin Anaesthesiol 25, 411\u2013418 (2012).","journal-title":"Curr Opin Anaesthesiol"},{"key":"28754_CR19","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1124\/mol.117.110569","volume":"93","author":"G Akk","year":"2018","unstructured":"Akk, G., Shin, D. J., Germann, A. L. & Steinbach, J. H. GABAA receptor activation in the allosteric coagonist model framework: relationship between EC50 and basal activity. Mol Pharmacol 93, 90\u2013100 (2018).","journal-title":"Mol Pharmacol"},{"key":"28754_CR20","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1124\/mol.117.110403","volume":"93","author":"DJ Shin","year":"2018","unstructured":"Shin, D. J. et al. Propofol is an allosteric agonist with multiple binding sites on concatemeric ternary GABAA receptors. Mol Pharmacol 93, 178\u2013189 (2018).","journal-title":"Mol Pharmacol"},{"key":"28754_CR21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/ALN.0b013e31823d0c36","volume":"116","author":"D Ruesch","year":"2012","unstructured":"Ruesch, D., Neumann, E., Wulf, H. & Forman, S. A. An allosteric coagonist model for propofol effects on \u03b11\u03b22\u03b32L \u03b3-aminobutyric acid type A receptors. Anesthesiology 116, 47\u201355 (2012).","journal-title":"Anesthesiology"},{"key":"28754_CR22","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1124\/mol.117.109595","volume":"92","author":"DJ Shin","year":"2017","unstructured":"Shin, D. J., Germann, A. L., Steinbach, J. H. & Akk, G. The actions of drug combinations on the GABAA receptor manifest as curvilinear isoboles of additivity. Mol Pharmacol 92, 556\u2013563 (2017).","journal-title":"Mol Pharmacol"},{"key":"28754_CR23","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0006-8993(97)01334-6","volume":"784","author":"DW Lam","year":"1998","unstructured":"Lam, D. W. & Reynolds, J. N. Modulatory and direct effects of propofol on recombinant GABAA receptors expressed in Xenopus oocytes: influence of \u03b1 and \u03b32 subunits. Brain Res 784, 179\u2013187 (1998).","journal-title":"Brain Res"},{"key":"28754_CR24","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1096\/fj.02-0611fje","volume":"17","author":"R Jurd","year":"2003","unstructured":"Jurd, R. et al. General anesthetic actions in vivo strongly attenuated by a point mutation in the GABAA receptor \u03b23 subunit. FASEB J 17, 250\u2013252 (2003).","journal-title":"FASEB J"},{"key":"28754_CR25","doi-asserted-by":"publisher","first-page":"8608","DOI":"10.1523\/JNEUROSCI.23-24-08608.2003","volume":"23","author":"DS Reynolds","year":"2003","unstructured":"Reynolds, D. S. et al. Sedation and anesthesia mediated by distinct GABAA receptor isoforms. J Neurosci 23, 8608\u20138617 (2003).","journal-title":"J Neurosci"},{"key":"28754_CR26","doi-asserted-by":"publisher","first-page":"7749","DOI":"10.1073\/pnas.92.17.7749","volume":"92","author":"U Gunther","year":"1995","unstructured":"Gunther, U. et al. Benzodiazepine-insensitive mice generated by targeted disruption of the \u03b32 subunit gene of \u03b3-aminobutyric acid type A receptors. Proc Natl Acad Sci USA 92, 7749\u20137753 (1995).","journal-title":"Proc Natl Acad Sci USA"},{"key":"28754_CR27","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/338582a0","volume":"338","author":"DB Pritchett","year":"1989","unstructured":"Pritchett, D. B. et al. Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology. Nature 338, 582\u2013585 (1989).","journal-title":"Nature"},{"key":"28754_CR28","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/2798","volume":"1","author":"C Essrich","year":"1998","unstructured":"Essrich, C., Lorez, M., Benson, J. A., Fritschy, J. M. & Luscher, B. Postsynaptic clustering of major GABAA receptor subtypes requires the \u03b32 subunit and gephyrin. Nat Neurosci 1, 563\u2013571 (1998).","journal-title":"Nat Neurosci"},{"key":"28754_CR29","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1124\/mol.104.007385","volume":"67","author":"PS Mangan","year":"2005","unstructured":"Mangan, P. S. et al. Cultured hippocampal pyramidal neurons express two kinds of GABAA receptors. Molecular Pharmacology 67, 775\u2013788 (2005).","journal-title":"Molecular Pharmacology"},{"key":"28754_CR30","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/cne.20897","volume":"495","author":"CC Swanwick","year":"2006","unstructured":"Swanwick, C. C., Murthy, N. R., Mtchedlishvili, Z., Sieghart, W. & Kapur, J. Development of \u03b3-aminobutyric acidergic synapses in cultured hippocampal neurons. J Comp Neurol 495, 497\u2013510 (2006).","journal-title":"J Comp Neurol"},{"key":"28754_CR31","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1476-5381.1981.tb09969.x","volume":"74","author":"CD Richards","year":"1981","unstructured":"Richards, C. D. & White, A. E. Additive and non-additive effects of mixtures of short-acting intravenous anaesthetic agents and their significance for theories of anaesthesia. Br J Pharmacol 74, 161\u2013170 (1981).","journal-title":"Br J Pharmacol"},{"key":"28754_CR32","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1007\/s00213-016-4369-8","volume":"233","author":"BW Gunter","year":"2016","unstructured":"Gunter, B. W., Jones, S. A., Paul, I. A., Platt, D. M. & Rowlett, J. K. Benzodiazepine and neuroactive steroid combinations in rats: anxiolytic-like and discriminative stimulus effects. Psychopharmacology (Berl) 233, 3237\u20133247 (2016).","journal-title":"Psychopharmacology (Berl)"},{"key":"28754_CR33","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1124\/jpet.111.180422","volume":"337","author":"BD Fischer","year":"2011","unstructured":"Fischer, B. D. & Rowlett, J. K. Anticonflict and reinforcing effects of triazolam\u2009+\u2009pregnanolone combinations in rhesus monkeys. J Pharmacol Exp Ther 337, 805\u2013811 (2011).","journal-title":"J Pharmacol Exp Ther"},{"key":"28754_CR34","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0022-3565(24)36837-5","volume":"282","author":"M Gasior","year":"1997","unstructured":"Gasior, M., Carter, R. B., Goldberg, S. R. & Witkin, J. M. Anticonvulsant and behavioral effects of neuroactive steroids alone and in conjunction with diazepam. J Pharmacol Exp Ther 282, 543\u2013553 (1997).","journal-title":"J Pharmacol Exp Ther"},{"key":"28754_CR35","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.nbd.2004.08.006","volume":"17","author":"DF Wozniak","year":"2004","unstructured":"Wozniak, D. F. et al. Apoptotic neurodegeneration induced by ethanol in neonatal mice is associated with profound learning\/memory deficits in juveniles followed by progressive functional recovery in adults. Neurobiol Dis 17, 403\u2013414 (2004).","journal-title":"Neurobiol Dis"},{"key":"28754_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/srep38808","volume":"6","author":"C Emnett","year":"2016","unstructured":"Emnett, C. et al. A Clickable analogue of ketamine retains NMDA receptor activity, psychoactivity, and accumulates in neurons. Sci Rep 6, 38808 (2016).","journal-title":"Sci Rep"},{"key":"28754_CR37","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1111\/bph.13007","volume":"172","author":"CM Emnett","year":"2015","unstructured":"Emnett, C. M. et al. Interaction between positive allosteric modulators and trapping blockers of the NMDA receptor channel. Br J Pharmacol 172, 1333\u20131347 (2015).","journal-title":"Br J Pharmacol"},{"key":"28754_CR38","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1152\/jn.1995.73.1.320","volume":"73","author":"S Mennerick","year":"1995","unstructured":"Mennerick, S., Que, J., Benz, A. & Zorumski, C. F. Passive and synaptic properties of hippocampal neurons grown in microcultures and in mass cultures. J Neurophysiol 73, 320\u2013332 (1995).","journal-title":"J Neurophysiol"},{"key":"28754_CR39","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0022-3565(25)22567-8","volume":"270","author":"SA Zimmerman","year":"1994","unstructured":"Zimmerman, S. A., Jones, M. V. & Harrison, N. L. Potentiation of \u03b3-aminobutyric acid A receptor Cl- current correlates with in vivo anesthetic potency. J Pharmacol Exp Ther 270, 987\u2013991 (1994).","journal-title":"J Pharmacol Exp Ther"},{"key":"28754_CR40","doi-asserted-by":"publisher","first-page":"46020","DOI":"10.1074\/jbc.M207663200","volume":"277","author":"SW Baumann","year":"2002","unstructured":"Baumann, S. W., Baur, R. & Sigel, E. Forced subunit assembly in \u03b11\u03b22\u03b32 GABAA receptors. Insight into the absolute arrangement. J Biol Chem 277, 46020\u201346025 (2002).","journal-title":"J Biol Chem"},{"key":"28754_CR41","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1124\/mol.111.071662","volume":"80","author":"J Bracamontes","year":"2011","unstructured":"Bracamontes, J. et al. Occupation of Either Site for the Neurosteroid Allopregnanolone Potentiates the Opening of the GABAA Receptor Induced from Either Transmitter Binding Site. Mol Pharmacol 80, 79\u201386 (2011).","journal-title":"Mol Pharmacol"},{"key":"28754_CR42","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S0022-2836(65)80285-6","volume":"12","author":"J Monod","year":"1965","unstructured":"Monod, J., Wyman, J. & Changeux, J. P. On the nature of allosteric transitions: a plausible model. J Mol Biol 12, 88\u2013118 (1965).","journal-title":"J Mol Biol"},{"key":"28754_CR43","doi-asserted-by":"publisher","first-page":"772","DOI":"10.2174\/1570159X14666160202121319","volume":"14","author":"MM Eaton","year":"2016","unstructured":"Eaton, M. M. et al. Multiple non-equivalent interfaces mediate direct activation of GABAA receptors by propofol. Curr Neuropharmacol 14, 772\u2013780 (2016).","journal-title":"Curr Neuropharmacol"},{"key":"28754_CR44","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/978-1-61779-334-9_17","volume":"796","author":"SA Forman","year":"2012","unstructured":"Forman, S. A. & Stewart, D. Mutations in the GABAA receptor that mimic the allosteric ligand etomidate. Methods Mol Biol 796, 317\u2013333 (2012).","journal-title":"Methods Mol Biol"},{"key":"28754_CR45","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1124\/mol.117.110569","volume":"93","author":"G Akk","year":"2018","unstructured":"Akk, G., Shin, D. J., Germann, A. L. & Steinbach, J. H. GABA type A receptor activation in the allosteric coagonist model framework: relationship between EC50 and basal activity. Mol Pharmacol 93, 90\u2013100 (2018).","journal-title":"Mol Pharmacol"},{"key":"28754_CR46","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1113\/jphysiol.2001.012818","volume":"537","author":"JH Steinbach","year":"2001","unstructured":"Steinbach, J. H. & Akk, G. Modulation of GABAA receptor channel gating by pentobarbital. J Physiol 537, 715\u2013733 (2001).","journal-title":"J Physiol"},{"key":"28754_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-16010-3","volume":"7","author":"CC Hernandez","year":"2017","unstructured":"Hernandez, C. C. et al. GABAA receptor coupling junction and pore GABRB3 mutations are linked to early-onset epileptic encephalopathy. Sci Rep 7, 15903 (2017).","journal-title":"Sci Rep"},{"key":"28754_CR48","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1016\/S0006-3495(99)77089-X","volume":"77","author":"Y Chang","year":"1999","unstructured":"Chang, Y. & Weiss, D. S. Allosteric activation mechanism of the \u03b11\u03b22\u03b32 \u03b3-aminobutyric acid type A receptor revealed by mutation of the conserved M2 leucine. Biophys J 77, 2542\u20132551 (1999).","journal-title":"Biophys J"},{"key":"28754_CR49","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/366565a0","volume":"366","author":"J Amin","year":"1993","unstructured":"Amin, J. & Weiss, D. S. GABAA receptor needs two homologous domains of the \u03b2-subunit for activation by GABA but not by pentobarbital. Nature 366, 565\u2013569 (1993).","journal-title":"Nature"},{"key":"28754_CR50","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nature05324","volume":"444","author":"AM Hosie","year":"2006","unstructured":"Hosie, A. M., Wilkins, M. E., da Silva, H. M. & Smart, T. G. Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites. Nature 444, 486\u2013489 (2006).","journal-title":"Nature"},{"key":"28754_CR51","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0165-6147(97)90675-1","volume":"18","author":"E Sigel","year":"1997","unstructured":"Sigel, E. & Buhr, A. The benzodiazepine binding site of GABAA receptors. Trends Pharmacol Sci 18, 425\u2013429 (1997).","journal-title":"Trends Pharmacol Sci"},{"key":"28754_CR52","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1113\/jphysiol.2007.134445","volume":"583","author":"EA Mitchell","year":"2007","unstructured":"Mitchell, E. A., Gentet, L. J., Dempster, J. & Belelli, D. GABAA and glycine receptor-mediated transmission in rat lamina II neurones: relevance to the analgesic actions of neuroactive steroids. J Physiol 583, 1021\u20131040 (2007).","journal-title":"J Physiol"},{"key":"28754_CR53","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1124\/mol.106.033407","volume":"71","author":"P Li","year":"2007","unstructured":"Li, P. et al. Natural and enantiomeric etiocholanolone interact with distinct sites on the rat \u03b11\u03b22\u03b32L GABAA receptor. Mol Pharmacol 71, 1582\u20131590 (2007).","journal-title":"Mol Pharmacol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28754-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28754-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28754-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T14:47:48Z","timestamp":1751726868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28754-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,9]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["28754"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-28754-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,9]]},"assertion":[{"value":"27 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"10341"}}